LabEx IBEID – Integrative Biology of Emerging Infectious Diseases
LabEx IBEID : Biologie Intégrative des Maladies Infectieuses Emergentes Le but du projet Biologie Intégrative des Maladies Infectieuses Emergentes (IBEID), initié par les professeurs Philippe Sansonetti et Pascale Cossart et actuellement coordonné par Carla […]
Primavera (Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance)
Désolé, cet article est seulement disponible en anglais américain.
Infections REspiratoires basses et sePSIs : Impact de la COvid19 – REPSICO
Le sepsis est un problème de santé important et serait responsable de millions de décès dans le monde selon l’OMS. En France, une récente étude montre qu’entre 2015 et 2019, l’incidence du sepsis bactérien […]
INDUCE: INciDence and conseqUenCes of sEpsis in France
As recently acknowledged by the WHO, sepsis is the number one killer from infectious diseases, mostly bacterial infections, and as such has emerged as a major public health priority. Global estimates ascribe to sepsis […]
BactHub: Antibiotic exposure and antibiotic-resistant bacteremia in the community
Antibiotic resistance rates are increasing worldwide, especially for Gram-negative bacteria, potentially responsible for difficult-to-treat infections and therapeutic failures. While the high prevalence of resistance in hospitals is a long-lived concern, resistance is now spreading […]
Project MOD-COV (Modelling of the hOspital Dissemination of SARS-CoV-2) In the context of SARS-CoV-2 pandemic, healthcare institutions are confronted to major challenges. First the community spread is leading to a large demand in available […]
I-Share is an Internet-based Students HeAlth Research Enterprise. It is an entirely new, prospective cohort of 30,000 students registered in the first years of study at the Universities of Bordeaux and Versailles-Saint-Quentin during five years and followed […]
Modelling Infection Spread in Hospitals
Despite advances in modern biology and medicine, antibiotic-resistant bacteria (ARB) have spread in the community and in hospitals over the last decades, becoming a major public health problem. Mathematical modeling and computer simulations are […]
MIBAC: Antibiotic use in the community
Since 2002 a centralized storage of therapeutic or preventive medications of bacterial infections in the community (MIBAC) has been initiated. Reimbursements for all systemic antibiotics (class J01 of the Anatomical Therapeutic classification), as well […]
PHIBRA: Bacterial resistance to antibiotics
Bacterial resistance to antibiotics has become a major public health issue. A recent report, delivered to the Minister of Health in September 2015, pointed out 158,000 cases of infections by antibiotic-resistant bacteria annually in […]
I-BIRD: Individual Based Investigation of Resistance Dissemination
The i-Bird program was devoted to explore the ability of MRSA and ER3GC to disseminate within hospital clinical departments. This program involved tracing the clonal dissemination of MRSA and ER3GC among hospitalized patients and […]
Ad hoc epidemiological investigations
Current research investigations Antibiotic use and Staphylococcus aureus resistant to antibiotics, ASAR This study is a prospective pharmacoepidemiological investigation involving the establishment of a cohort of hospitalized individuals not initially colonized with S. aureus. […]
Current and future research programs
Challenges in understanding the determinants of anti-infection agent escape New antibiotic components are being developed and, provided the necessary investments are made, new antibiotics may therefore become available within the next few years. […]
Main achievements over the last 5 years
Determinants of the spread and competitiveness of multiresistant bacteria In 2000, we investigated whether pneumococcal resistance to penicillin G in a child population could be controlled by modifying the use of antibiotics in […]
2023Determinants of worldwide antibiotic resistance dynamics across drug-bacterium pairs: a multivariable spatial-temporal analysis using ATLAS., Lancet Planet Health 2023 Jul; 7(7): e547-e557.
2023Inappropriate antibiotic prescribing and its determinants among outpatient children in 3 low- and middle-income countries: A multicentric community-based cohort study., PLoS Med 2023 Jun; 20(6): e1004211.
2023Stillbirths and neonatal mortality in LMICs: A community-based mother-infant cohort study., J Glob Health 2023 Apr; 13(): 04031.
2022One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality-a French nationwide study., Crit Care 2022 Nov; 26(1): 371.
2022Prevalence and factors associated with faecal carriage of extended-spectrum β-lactamase-producing Enterobacterales among peripartum women in the community in Cambodia., J Antimicrob Chemother 2022 Jul; (): .
2022Antimicrobial Resistance and Mortality in Hospitalized Patients with Bacteremia in the Greater Paris Area from 2016 to 2019., Clin Epidemiol 2022 ; 14(): 1547-1560.
2021Lockdown impact on age-specific contact patterns and behaviours, France, April 2020., Euro Surveill 2021 12; 26(48): .
2021Severe bacterial neonatal infections in Madagascar, Senegal, and Cambodia: A multicentric community-based cohort study., PLoS Med 2021 Sep; 18(9): e1003681.
2021Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS), BMC Infect Dis 2021 Jun; 21(1): 571.
2021Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017, Int J Antimicrob Agents 2021 Jun; 57(6): 106339.
+Voir la liste complète de publications